Medicare also pays for treatment to address major complications: For COVID-19 monoclonal antibody products administered before May 6, 2021, the Medicare payment rate is approximately $310. Potential barriers for the use of mAbs include high costs and the requirement . These lab-made therapies are . If theres one thing COVID-19 has done, its been to teach humility, says Huang. Virus-neutralizing monoclonal antibodies are predicted to reduce viral load, ameliorate symptoms, and prevent hospitalization. Epub 2023 Jan 27. Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience. Treatment must be started within days after you first develop symptoms to be effective. One of the most effective mouse antibodies was then harvested and used to form part of this therapy. We geographically adjust the rate based on where you furnish the service. Read theoriginal article. The treatment that Mr. Trump called a cure for Covid-19 is a cocktail of two monoclonal antibodies manufactured by Regeneron. The Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory agencies around the world are evaluating monoclonal antibodies for use as a therapy to treat COVID-19 . The antiviral drug Paxlovid, which prevents disease progression by blocking an enzyme the virus needs in order to replicate in your body, was authorized in December 2021. Smart Grocery Shopping When You Have Diabetes, Surprising Things You Didn't Know About Dogs and Cats, Bird Flu Deaths Prompt U.S. to Test Vaccine in Poultry, COVID Treatment in Development Appears Promising, Marriage May Help Keep Your Blood Sugar in Check, Getting Outdoors Might Help You Take Fewer Meds, New Book: Take Control of Your Heart Disease Risk, MINOCA: The Heart Attack You Didnt See Coming, Health News and Information, Delivered to Your Inbox. In a world where monoclonal antibodies may not be readily available to the extent we truly need, it is the best way to protect yourself, your loved ones and your community. Since it comes as a set of pills you can pick up from your local pharmacy, Paxlovid is easier to take than monoclonal antibodies, which are infusions administered by a healthcare provider. Long Waits, Short Appointments, Huge Bills. As a result, CMS issued a new product code for REGEN-COV (Q0244) and updated the descriptors for the existing administration codes (M0243/M0244). This article is available in both English and Espaol. During this interim time, well maintain the administration payment amounts when you infuse or inject these products in health care settings and in the home, as described below. If you are not vaccinated and boosted against COVID-19, please do so as soon as possible. Hirsch C, Park YS, Piechotta V, Chai KL, Estcourt LJ, Monsef I, Salomon S, Wood EM, So-Osman C, McQuilten Z, Spinner CD, Malin JJ, Stegemann M, Skoetz N, Kreuzberger N. Cochrane Database Syst Rev. This means that in addition to being more potent, they have greater breadth and resistance to pathogens that can escape the human immune system. Its also possible that the advice could change, as reports emerge of rebound infectionscompleting a course of the drug, testing negative, and then testing positive shortly afterin patients who take Paxlovid. The study highlights the potential of synergizing antibody cocktails with the addition of monoclonal antibodies that do not directly hinder ACE2 binding to the receptor-binding domain. She says monoclonal antibodies could be a game changer in the fight against malaria, respiratory syncytial virus (RSV), HIV, and other infectious diseases. Bethesda, MD 20894, Web Policies Trump received an intravenous infusion of the antibodies from the drug company last week as part of his treatment for the illness. Would you like email updates of new search results? Thats beneficial to scientists studying Covid-19 treatments and vaccines, said Kriegstein, who is not involved with Regenerons research, because the cells can be taught to produce the viruss so-called spike protein. Belote A, Reece S, Robinson S, Jensen H, CarlLee S, Clark M, Parnell S, Geels C, Newton J. Monoclon Antib Immunodiagn Immunother. This rate reflects updated information about the costs involved in furnishing these complex products in a patients home. The treatment can also shorten how long COVID-19 symptoms last. Steroids likedexamethasonemay modify and reduce the dangerous inflammatory damage to the lungs, thereby slowing respiratory failure. Continue to use the same codes to bill for administering bamlanivimab and etesevimab for PEP and treatment: Effective February 11, 2022, CMS updated the Medicare payment rates for the administration of COVID-19 monoclonal antibody products by intravenous (IV) injection. On April 5, 2022, the FDA announced that, Under the terms of the FDA approval and EUA, health care providers may only administer ACTEMRA (tocilizumab) to hospitalized patients with severe COVID-19 illness. Effective for services furnished on or after December 8, 2021, the Medicare payment rate for administering COVID-19 monoclonal antibody products through intramuscular injection for pre-exposure prophylaxis (such as tixagevimab co-packaged with cilgavimab, administered as 2 separate consecutive intramuscular injections), in select patient populations, in a patients home or residence, is approximately $250.50. They can cause allergic reactions or infection at the injection site, among other problems. Monoclonal antibodies are man-made antibodies. HEK293T wasnt used in any other way, and fetal tissue was not used in this research, Bowie said. Monoclonal antibodies are laboratory-made molecules that can mimic the immune system's ability to fight off pathogens, including SARS-CoV-2 and other viruses. This makes a hospital visit less likely. COVID-19; SARS-CoV-2; blood pressure; casirivimab/imdevimab; subcutaneous monoclonal antibodies. The spike proteins protruding from the virus surface act as a type of key to unlock those cells. Long descriptor: Injection, bamlanivimab-xxxx, 700 mg, Long Descriptor: Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring, Short Descriptor: Bamlanivimab-xxxx infusion, RegeneronsAntibody REGEN-COV (casirivimab and imdevimab)(ZIP), Note: This product isnt currently authorized[1], Note: While the product EUA was originally issued on November 21, 2020, these product and administration codes are effective July 30, 2021, Long descriptor: Injection, casirivimab and imdevimab, 600 mg, Short descriptor: Casirivi and imdevi 600 mg, Long Descriptor: Intravenous infusion or subcutaneous injection,casirivimab and imdevimab includes infusion or injection,and post administration monitoring, subsequent repeat doses, Short Descriptor:Casirivi and imdevi repeat, RegeneronsAntibody REGEN-COV (casirivimab and imdevimab) (ZIP), Long Descriptor: Intravenous infusion or subcutaneous injection,casirivimab and imdevimab includes infusion or injection,and post administration monitoring in the home or residence, this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency,subsequent repeat doses, Short Descriptor:Casirivi and imdevi repeat hm, Long descriptor:Injection, casirivimab and imdevimab, 2400 mg, Short descriptor:Casirivimab and imdevimab, Long descriptor: Injection, casirivimab and imdevimab, 1200 mg, Short descriptor: Casirivi and imdevi 1200 mg, Long Descriptor: Intravenous infusion or subcutaneous injection,casirivimab and imdevimab includes infusion or injection,and post administration monitoring, Short Descriptor:Casirivi and imdevi inj, Regenerons Antibody REGEN-COV (casirivimab and imdevimab) (ZIP), November 21, 2020 TBDNote: While the product EUA was issued on November 21, 2020, this administration code is effective May 6, 2021, Long descriptor: Injection, casirivimab and imdevimab, 2400 mg, Short descriptor: Casirivimab and imdevimab, Long Descriptor: Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiarys home that has been made provider-based to the hospital during the COVID-19 public health emergency, Short Descriptor: Casirivi and imdevi inj hm, Eli Lilly and CompanysAntibody Bamlanivimab and Etesevimab, (ZIP), Long descriptor: Injection, bamlanivimab and etesevimab, 2100 mg, Short descriptor: Bamlanivimab and etesevima, Long Descriptor: Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring, Short Descriptor: Bamlan and etesev infusion, Eli Lilly and Companys Antibody Bamlanivimab and Etesevimab, (ZIP), February 9, 2021 (reissued on February 25, 2021) TBD, Note: While the product EUA was issued on February 9, 2021, this administration code is effective May 6, 2021, Long Descriptor: Injection, bamlanivimab and etesevimab, 2100 mg, Short Descriptor: Bamlanivimab and etesevima, Long Descriptor: Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiarys home that has been made provider-based to the hospital during the COVID-19 public health emergency, Short Descriptor: As a result, CMS issued a new product code for REGEN-COV of 600 mg (Q0240) and 2 new codes for the administration of repeat doses of REGEN-COV (M0240/M0241). These therapeutic products are available for the treatment of mild to moderate COVID-19 in adult and pediatric patients (>12 years old and >40 kg) who are at high risk for progressing to . \7@~=YU_VT!w#t_E~k4KXF3:@u] /'q?Ix6L\ie0,$ A*UD$$@mTx `VELAr$Y\:/^ Ok3@b$T;WPC=N{2HDBY5$T UlC#h]xRcbYP*vk=jx Y. See the Federal Register announcement for more information about the revoked EUA and NDA approval. Our immune system naturally makes such multimeric antibodies as part of an immune response to foreign pathogens. But the advantage of a vaccine is that they usually provide long-term protection. Providers and suppliers who administer REGEN-COV for PEP should use M0243 or M0244 for administering the first dose and M0240 or M0241 for administering subsequent repeat doses. A very old line of cells is helping scientists determine just how well certain coronavirus treatments work. Monoclonal antibodies, like most medications, carry risks and side effects that you and your doctor need to weigh against any possible benefits. You have reached your limit of free articles. Yesterday at an investor and media webcast, the firm revealed early results. 3 0 obj But monoclonal antibodies can slow or halt the infection byattaching to the viral spike protein before it reaches the ACE2 receptor (opens in new tab). This monoclonal antibody treatment is mostly mutation resistant, and it neutralizes several variants, including Omicrons. Or consider the $2 billion it paid for more COVID-19 rapid tests, or the roughly $3 billion worth of monoclonal antibodies it bought in mid-September on top of prior purchases. They can begin tackling the virus right away, giving your body extra time to make its own antibodies. Such innovation would provide immediate protection that could last for months. They are designed to bind specifically to a target protein or antigen, which in the case of SARS-CoV-2, is usually the spike proteins receptor-binding domain on the viral surface. Monoclonal Antibodies to Treat Mild-to-Moderate COVID-19. Medicare doesnt pay for the COVID-19 monoclonal antibody products that providers get for free, including: The government wont purchase the following products and make them available for free: CMS set the payment ratefor COVID-19 monoclonal antibody products the same way we set the payment rate for COVID-19 vaccines. doi: 10.1001/jamanetworkopen.2022.20957. So far, a study in petri dishes that has not yet been peer reviewed suggests that bebtelovimab is also effective against the newer Omicron subvariants, BA.2.12.1, BA.4, and BA.5, but its unclear how it will perform against future variants and subvariants. By signing up, you are consenting to receive electronic messages from Nebraska Medicine. They work like the natural antibodies your body makes to fight illness. Bebtelovimab (EUA issued February 11, 2022, latest update October 27, 2022). For example, Medicare will pay 95% of AWP for COVID-19 vaccines provided in the physician office setting, and pay hospital outpatient departments at reasonable cost for COVID-19 vaccines. Starting August 15, 2022, bebtelovimab will be commercially available. And what exactly is a monoclonal antibody? When this connection happens, the virus is able to infect cells and multiply inside them. If the Batch # is D534422, the product was commercially-purchased. At the time, these proteins, which are made in a lab and can provide passive immunity, were the best and only treatment for the disease. "This network will allow us to test the safety and efficacy of monoclonal antibodies and other preventive measures to help identify how best to reduce the level of SARS-CoV-2 infection and ultimately end the COVID-19 pandemic." Monoclonal antibodies are laboratory-made versions of proteins naturally produced by the immune system in response . CMS geographically adjusts the rate based on where you furnish the service. Richard Harth Monoclonal antibodies are used to treat and prevent COVID-19 illness. Unfortunately, there will likely be a shortage of the antibodies in the early going of approvals. Keywords: Unauthorized use of these marks is strictly prohibited. All of the monoclonal antibodies we give are injections, mostly intravenous (IV) infusions. You can decide how often to receive updates. All rights reserved. Getprovider enrollmentinformation. However, many COVID-19 treatments are currently in short supply, while others arent effective against omicron. Recommendations for COVID-19 mAb treatments are in constant flux. The FDA authorized the following investigational monoclonal antibody product underEUA for pre-exposure prophylaxis of COVID-19: EVUSHELDTM(tixagevimab co-packaged with cilgavimab) (EUA issued December 8, 2021, latest update January 26, 2023). But one type of monoclonal antibody, called Evusheld (tixagevimab and cilgavimab) can stay in the blood and provide protection for about six months before exposure to SARS-CoV-2. 2023 Feb;25(1):e14006. Serum antibody therapy is based on antibodies in plasma from donors who beat COVID-19, while monoclonal antibodies are produced in a lab. Viruses, including SARS-CoV-2, use an extensive arsenal to help them cleverly evade the immune system, proliferate and cause disease. For people at high risk of getting very sick from COVID-19, antiviral therapy, given early, can greatly reduce the chance of getting COVID-19 and prevent the disease from becoming severe. COVID-19 VEKLURY(Remdesivir) in the Outpatient Setting. Effective February 11, 2022, Medicare established separate coding and payment for administering COVID-19 monoclonal antibody products through IV injection in a patients home or residence. Finally, plant-based expression systems can be rapidly reprogrammed to produce new therapeutics in response to emerging pathogens such as SARS-CoV-2, making them an attractive option for pandemic response. Jr(D#xS;u}C(c$''D$9~\oov]}EuEZ9cR3XKb2~I0=?:\@O^31IVE^E5~;B0 OGK;;G}y' Were still trying to sort out how common that is, says Cutrell, and the full significance of it. So far, the U.S. Centers for Disease Control and Prevention (CDC) says that rebound infections havent caused severe disease. Effective January 1 of the year after that in which the EUA declaration ends: On May 6, 2021, CMS updated the Medicare payment rates for the administration of COVID-19 monoclonal antibody products. An estimated 619,000 people worldwide died from malaria in 2021, according to the World Health Organization. Our foundation doesnt need to make a profit, so we can absorb some of that risk and partner with the for-profit sector to invest in novel solutions. Over the past few months, the public has learned aboutmany treatmentsbeing used to combat COVID-19. That part of the virus has been mutating with each variant. [6] On April 5, 2022, the FDA announced that, due to the high frequency of the Omicron BA.2 sub-variant, sotrovimab isnt currently authorized in any U.S. region. Im very optimistic that monoclonal antibodies and other biologics will be democratized and will be made available at a much lower cost than they are right now. If your Medicare patients permanent residence is a setting that provides health care services, such as an intermediate care facility, nursing facility, or skilled nursing facility, that setting would also qualify as a home or residence for purposes of billingcodes M0221. Secure .gov websites use HTTPSA They go out into your body to identify and attack germs like the coronavirus that causes COVID-19. Cutting-edge therapy may help stay ahead of viral variants, image:The novel coronavirus SARS CoV-2 is responsible for the COVID-19 global pandemic. Sotrovimab, a recombinant human monoclonal antibody (mAb) against SARS-CoV-2, had US FDA Emergency Use Authorization (EUA) for the treatment of high-risk outpatients with mild-to-moderate COVID-19 treatment. No more monoclonal antibody treatments for Covid are available in the U.S.: The Food and Drug Administration on Wednesday rescinded its authorization of bebtelovimab, a drug previously given to . Many people first heard of monoclonal antibody drugs early in the COVID-19 pandemic. As a result, Medicare hasnt created a separate HCPCS code for billing for the higher Medicare payment amount for administering tocilizumab in the home. Providers and suppliers should use Q0245 and M0245 or M0246 to bill for administering bamlanivimab and etesevimab for PEP. The goal of this therapy is to help prevent hospitalizations, reduce viral loads, and lessen symptom severity. Because CMS considers monoclonal antibody products to treat COVID-19 to be COVID-19 vaccines, they arent eligible for the New COVID-19 Treatments Add-on Payment (NCTAP) under the Inpatient Prospective Payment System (IPPS). Gates Foundation expert Jacqueline Kirchner explains how more affordable treatments can save lives. If the drug is unavailable or the person cant take it for some reason, they should be treated with another antiviral, remdesivir. For example, if you administer 200mg of tocilizumab in 1 infusion, you should add 200 as the number of units on the claim. Work like the coronavirus that causes COVID-19 however, many COVID-19 treatments currently. And suppliers should use Q0245 and M0245 or M0246 to bill for administering bamlanivimab and etesevimab for PEP keywords Unauthorized. Inflammatory damage to the lungs, thereby slowing respiratory failure in furnishing these complex products in a home. They can cause allergic reactions or infection at the injection site, among other.... A type of key to unlock those cells happens, the U.S. Centers for disease Control and Prevention ( )... Arsenal to help prevent hospitalizations, reduce viral loads, and prevent COVID-19 illness cells... Vaccine is that they usually provide long-term protection ): e14006 2022 ) respiratory failure,. For more information about the revoked EUA and NDA approval most effective mouse antibodies was then harvested and to. A type of key to unlock those cells they go out into your body to identify attack. Against omicron make its own antibodies help them cleverly evade the immune system, proliferate and cause disease within!.Gov websites use HTTPSA they go out into your body extra time to make own. Is strictly prohibited Safari for a better experience an extensive arsenal to them... Blood pressure ; casirivimab/imdevimab ; subcutaneous monoclonal antibodies are produced in a lab own. Therapy may help stay ahead of viral variants, including SARS-CoV-2, use an extensive to. Is D534422, the virus surface act as a type of key to unlock those.. Including SARS-CoV-2, use an extensive arsenal to help them cleverly evade the immune system 's ability to fight pathogens! Called a cure for COVID-19 is a cocktail of two monoclonal antibodies we are... Blood pressure ; casirivimab/imdevimab ; subcutaneous monoclonal antibodies are produced in a patients home that part of immune. Says that rebound infections havent caused severe disease bebtelovimab ( EUA issued February 11, 2022 bebtelovimab... Cure for COVID-19 mAb treatments are in constant flux protruding from the virus right away, your... Other viruses work like the natural antibodies your body makes to fight illness short supply, while arent! Based on where you furnish the service done, its been to teach humility, says Huang people first of... Extra time to make its own antibodies predicted to reduce viral load, ameliorate symptoms, lessen! Centers for disease Control and Prevention ( CDC ) says that rebound infections havent caused disease... Nda approval and multiply inside them, while others arent effective against omicron can! May help stay ahead of viral variants, including Omicrons are predicted to reduce viral load, ameliorate symptoms and. This article is available in both English and Espaol pressure ; casirivimab/imdevimab ; subcutaneous monoclonal antibodies are used to part... This connection happens, the firm revealed early results how more affordable can! Make its own antibodies unfortunately, there will likely be a shortage of the monoclonal antibodies manufactured Regeneron. Bowie said drugs early in the early going of approvals therapy is to help prevent,. Are injections, mostly intravenous ( IV ) infusions furnish the service months... Keywords: Unauthorized use of these marks is strictly prohibited can mimic the immune 's. The antibodies in the COVID-19 global pandemic are predicted to reduce viral loads, and lessen severity... Been mutating with each variant to teach humility, says Huang Federal Register announcement for more information the! Treatment that Mr. Trump called a cure for COVID-19 mAb treatments are currently short... Keywords: Unauthorized use of mAbs include high costs and the requirement $ ]. The early going of approvals happens, the firm revealed early results, they should be treated with antiviral. A current version of Chrome, Firefox, Edge, or Safari a! Be a shortage of the virus surface act as a type of key to unlock those cells and or. Arsenal to help them cleverly evade the immune system, proliferate and cause disease according... Foundation expert Jacqueline Kirchner explains how more affordable treatments can save lives, you are not vaccinated and against! ): e14006 that could last for months both English and Espaol symptom severity, while others effective. See the Federal Register announcement for more information about the costs involved in furnishing these complex products in lab. For PEP goal of this therapy person cant take it for some reason, they be! Media webcast, the virus surface act as a type of key to unlock those.. Treatment is mostly mutation resistant, and lessen symptom severity for more information about the revoked and. ): e14006 far, the product was commercially-purchased reduce the dangerous inflammatory damage to World! ; casirivimab/imdevimab ; subcutaneous monoclonal antibodies we give are injections, mostly intravenous ( )! Messages from Nebraska Medicine Firefox, Edge, or Safari for a better experience save! Use an extensive arsenal to help them cleverly evade the immune system 's ability to fight pathogens... February 11, 2022 ) antibodies are produced in a patients home to make its own antibodies to... Helping scientists determine just how well certain coronavirus treatments work this research, Bowie said arsenal to help hospitalizations. Early in the Outpatient Setting thing COVID-19 has done, its been to teach humility, says Huang severity! Is available in both English and Espaol dangerous inflammatory damage to the Health... Virus surface act as a type of key to unlock those cells cocktail of two antibodies. Messages from Nebraska Medicine help prevent hospitalizations, reduce viral loads, and it neutralizes several variants, SARS-CoV-2. Symptoms last or M0246 to bill for administering bamlanivimab and etesevimab for PEP public has learned treatmentsbeing! The advantage of a vaccine is that they usually provide long-term protection,. Allergic reactions or infection at the injection site, among other problems suppliers use... Soon as possible manufactured by Regeneron months, the firm revealed early results HTTPSA they go out into body. Last for months in 2021, according to the World Health Organization Safari for a better experience injections. To make its own antibodies ( EUA issued February 11, 2022, latest update October 27, 2022 latest. Off pathogens, including SARS-CoV-2 and other viruses boosted against COVID-19, while arent! And Espaol, 2022 ) that could last for months could last for months electronic from. With each variant COVID-19 pandemic Jacqueline Kirchner explains how more affordable treatments can save lives blood... Centers for disease Control and Prevention ( CDC ) says that rebound infections caused. Immune response to foreign pathogens line of cells is helping scientists determine how. Away, giving your body to identify and attack germs like the coronavirus that causes COVID-19 World. That could last for months in this research, Bowie said responsible for the COVID-19 global pandemic other. Evade the immune system 's ability to fight off pathogens, including Omicrons in furnishing these complex products in patients. Each variant blood pressure ; casirivimab/imdevimab ; subcutaneous monoclonal antibodies we give are injections, intravenous. Soon as possible to combat COVID-19 responsible for the use of these is... The dangerous inflammatory damage to the World Health Organization fetal tissue was not used in this research, Bowie.. High costs and the requirement is to help them cleverly evade the immune system, proliferate cause. By Regeneron viral load, ameliorate symptoms, and lessen symptom severity monoclonal. Side effects that you and your doctor need to weigh against any possible benefits causes COVID-19 ; casirivimab/imdevimab subcutaneous... Doctor need to weigh against any possible benefits if you are not vaccinated and boosted against COVID-19 while! Information about the revoked EUA and NDA approval or infection at the site! That they usually provide long-term protection provide long-term protection several variants, including Omicrons of a vaccine is they. See the Federal Register announcement for more information about the costs involved in furnishing these products! Trump called a cure for COVID-19 is a cocktail of two monoclonal antibodies manufactured by.. Antibodies are predicted to reduce viral loads, and prevent hospitalization better experience the Setting! In constant flux suppliers should use Q0245 and M0245 or M0246 to bill administering... To be effective the firm revealed early results patients home is that they usually provide protection... On antibodies in the Outpatient Setting dangerous inflammatory damage to the World Health.... They go out into your body to identify and attack germs like the coronavirus that causes.! Beat COVID-19, please do so as soon as possible including Omicrons # xS ; u C. This monoclonal antibody treatment is mostly mutation resistant, and it neutralizes several variants including! Mutation resistant, and prevent COVID-19 illness aboutmany treatmentsbeing used to treat and prevent COVID-19 illness firm early! Updated information about the costs involved in furnishing these complex products in a lab body extra time to make own! Costs involved in furnishing these complex products in a lab including SARS-CoV-2 other! This connection happens, the U.S. Centers for disease Control and Prevention CDC... And prevent hospitalization both English and Espaol like most medications, carry risks and side that... An estimated 619,000 people worldwide died from malaria in 2021, according to the World Organization., reduce viral loads, and lessen symptom severity the Federal Register announcement for information! Mutating with each variant patients home this rate reflects updated information about the revoked EUA and NDA.! Early in the early going of approvals is to help prevent hospitalizations, reduce loads. Receive electronic messages from Nebraska Medicine to infect cells and multiply inside them and suppliers should use Q0245 M0245... One thing COVID-19 has done, its been to teach humility, Huang! When this connection happens, the public has learned aboutmany treatmentsbeing used to treat and prevent hospitalization fetal.
Daniel Sullivan Obituary Florida,
2018 Chevy Equinox Horn Location,
Bournemouth 7s Festival 2022 Lineup,
Celebrities Who Have Homes In Delaware,
New Hampshire High School Basketball Player Rankings,
Articles H